Asthma control versus asthma severity

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 I, 1996, Pages 1016-1018

  Cockcroft, D W ^a   Swystun, V A ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DRUG COST; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; PRIORITY JOURNAL; PSYCHOGENESIS; REVIEW; SINUSITIS;

EID: 0030444007     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)80185-0     Document Type: Article

References (5)

1. US Department of Health and Human Services International Consensus Report on Diagnosis and Treatment of Asthma 1992 National Heart, Lung, and Blood Institute Bethesda
2. M Kaliner Goals of asthma therapy Ann Allergy Asthma Immunol 75 1995 169 172
3. P Ernst JM Fitzgerald S Spier Canadian Asthma Consensus Conference: summary of recommendations Can Respir J 3 1996 89 100
4. MR Sears DR Taylor CG Print DC Lake Q Li EM Flannery Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
5. AT Kerigan SO Pugsley DW Cockcroft FE Hargreave Substitution of inhaled beclomethasone dipropionate for oral prednisone in steroid-dependent asthmatics Can Med Assoc J 116 1977 876 881